Healthcare

A special report on the healthcare sector; How Trump’s reforms are steering investors towards a new set of opportunities; Plus, expert comment from KPMG.

The past 12 months have seen plenty of private markets action in the healthcare sector, even as the regulatory environment gets tougher.

The investment bank has said it will no longer work with the tech and healthcare investor on placing its latest flagship fund, which is expected to seek at least €3bn.

China's CIC is the latest institution to consider offloading a sizeable private equity portfolio. Plus: Why US managers shouldn't count their chickens despite a regulatory shake up; and TPG adds to its PE leadership. Here's today's brief, for our valued subscribers only.

The healthcare sector – particularly for service provider assets in the US – has been in the spotlight of regulators, enforcers and legislators throughout 2024.

The growth investor will deploy more than 20% of its most recent USD-denominated flagship outside of Mainland China, chief executive Steven Wang told PEI.

Head of Australia and New Zealand Joel Thickins will jointly lead the Asia business alongside existing head Ganen Sarvananthan.

Documents prepared for a US pension shed light on the performance of the firm's growth funds as it seeks $9bn for its 12th vintage.

Key person clauses are coming under pressure at the negotiating table as LPs take advantage of fundraising headwinds. Plus: Who are the world's biggest impact allocators? Here's today's brief, for our valued subscribers only.

TPG is joining a host of firms looking to further tap private wealth capital. Plus: SoftBank's tiny profit and a milestone for the secondaries industry. Here's today's brief, for our valued subscribers only.